THE IMPACT OF INTERPLAY BETWEEN LDLR AND APOB MUTATIONS ON FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Thanh Kim [1 ]
Ngoc Nguyen [2 ]
Tung Le [2 ]
An Le [2 ]
Loi Do
Huong Truong [1 ,3 ]
机构：
[1] Hanoi Med Univ, Dept Cardiol, Hanoi, Vietnam
[2] Bach Mai Hosp, Vietnam Natl Heart Inst, Hanoi, Vietnam
[3] Phenikaa Univ, Fac Med, Hanoi, Vietnam
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P198
引用
收藏
页数：1
相关论文
共 50 条
  • [11] The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia
    Meshkov, Alexey
    Ershova, Alexandra
    Kiseleva, Anna
    Zotova, Evgenia
    Sotnikova, Evgeniia
    Petukhova, Anna
    Zharikova, Anastasia
    Malyshev, Pavel
    Rozhkova, Tatyana
    Blokhina, Anastasia
    Limonova, Alena
    Ramensky, Vasily
    Divashuk, Mikhail
    Khasanova, Zukhra
    Bukaeva, Anna
    Kurilova, Olga
    Skirko, Olga
    Pokrovskaya, Maria
    Mikova, Valeriya
    Snigir, Ekaterina
    Akinshina, Alexsandra
    Mitrofanov, Sergey
    Kashtanova, Daria
    Makarov, Valentin
    Kukharchuk, Valeriy
    Boytsov, Sergey
    Yudin, Sergey
    Drapkina, Oxana
    GENES, 2021, 12 (01) : 1 - 17
  • [12] PHENOTYPIC DIFFERENCES OF PATIENTS WITH MOLECULARLY DEFINED APOB AND LDLR DEFECTIVE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Vogt, A.
    Keller, C.
    Heigl, C.
    Weiss, N.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 166 - 166
  • [13] INSIGHTS INTO THE VIETNAM FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY: CHARACTERIZING MUTATIONS IN LDLR, APOB AND PCSK9 PROTEINS AT A STRUCTURAL AND FUNCTIONAL LEVEL
    Kim, Thanh
    Ngoc Nguyen
    Tung Le
    An Le
    Loi Do
    Huong Truong
    ATHEROSCLEROSIS, 2024, 395
  • [14] SCREENING FOR GENETIC MUTATIONS IN LDLR GENE WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE MONGOLIAN POPULATION
    Unurjargal, Tsolmon
    Byambatsogt, Bolortuul
    Sodovsuren, Naranchimeg
    Lhagvasuren, Sodnomtsogt
    JOURNAL OF HYPERTENSION, 2021, 39 : E266 - E266
  • [15] Detection of splice site mutations in the LDLR gene causing Familial Hypercholesterolemia
    McIlhatton, B
    Kirk, CW
    Lyttle, K
    Beattie, ED
    Hart, P
    Nicholls, DP
    Young, IS
    Graham, CA
    JOURNAL OF MEDICAL GENETICS, 2003, 40 : S80 - S80
  • [16] Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
    Hu, Haochang
    Shu, Tian
    Ma, Jun
    Chen, Ruoyu
    Wang, Jian
    Wang, Shuangshuang
    Lin, Shaoyi
    Chen, Xiaomin
    FRONTIERS IN GENETICS, 2021, 12
  • [17] Screening of APOB gene mutations in subjects with clinical diagnosis of familial hypercholesterolemia
    Meriño-Ibarra, E
    Castillo, S
    Mozas, P
    Cenarro, A
    Martorell, E
    Díaz, JL
    Suárez-Tembra, M
    Alonso, R
    Civeira, F
    Mata, P
    Pocoví, M
    HUMAN BIOLOGY, 2005, 77 (05) : 663 - 673
  • [18] Familial autosomal dominant hypercholesterolemia:: Highly skewed contribution of mutations in the LDLR, APOB, FH3 and FH4 genes
    Varret, M
    Abifadel, M
    Villéger, L
    Allard, D
    Devillers, M
    Erlich, D
    Junlen, C
    Bolleau, C
    Rabès, JP
    CIRCULATION, 2002, 106 (19) : 290 - 290
  • [19] PCSK9 analysis in familial hypercholesterolaemia patients negative for LDLR and APOB mutations
    George, P. M.
    Homer, V. M.
    Laurie, A. D.
    Hurndell, N.
    Scott, R. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 135 - 135
  • [20] Novel approaches to the detection of heterozygote LDLR mutations causing severe familial hypercholesterolemia
    Cantafora, A.
    Blotta, I.
    Pisciotta, L.
    Careri, R.
    Calandra, S.
    Bertolini, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 136 - 136
12345